Skip to main content
SpringerLink
Log in

Amphotericin-b-liposomal/methylprednisolone/voriconazole

COVID-19-associated pulmonary aspergillosis, lack of efficacy and off-label use: 10 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lee R, et al. Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: Multicenter retrospective cohort study. Korean Journal of Internal Medicine 37: 851-863, No. 4, Jul 2022. Available from: URL: http://doi.org/10.3904/kjim.2022.069

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amphotericin-b-liposomal/methylprednisolone/voriconazole. Reactions Weekly 1952, 47 (2023). https://doi.org/10.1007/s40278-023-37140-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-37140-z

Search

Navigation